FACULTAD DE FILOSOFÍA Y LETRAS
Facultad
Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas
Madrid, EspañaPublicaciones en colaboración con investigadores/as de Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (20)
2023
-
Analysis of retinal nerve layers in idiopathic, LRRK2-associated Parkinson's disease and unaffected carriers of G2019S mutation
Parkinsonism and Related Disorders, Vol. 106
-
Differential serum microRNAs in premotor LRRK2 G2019S carriers from Parkinson’s disease
npj Parkinson's Disease, Vol. 9, Núm. 1
2022
-
Sensor-based gait analysis in the premotor stage of LRRK2 G2019S-associated Parkinson's disease
Parkinsonism and Related Disorders, Vol. 98, pp. 21-26
2021
-
Finding genetically-supported drug targets for Parkinson’s disease using Mendelian randomization of the druggable genome
Nature Communications, Vol. 12, Núm. 1
-
Serial DaT-SPECT imaging in asymptomatic carriers of LRRK2 G2019S mutation: 8 years’ follow-up
European Journal of Neurology, Vol. 28, Núm. 12, pp. 4204-4208
2020
-
Regulatory sites for splicing in human basal ganglia are enriched for disease-relevant information
Nature Communications, Vol. 11, Núm. 1
2019
-
Mitochondria function associated genes contribute to Parkinson’s Disease risk and later age at onset
npj Parkinson's Disease, Vol. 5, Núm. 1
-
Moving beyond neurons: the role of cell type-specific gene regulation in Parkinson’s disease heritability
npj Parkinson's Disease, Vol. 5, Núm. 1
-
The Genetic Architecture of Parkinson Disease in Spain: Characterizing Population-Specific Risk, Differential Haplotype Structures, and Providing Etiologic Insight
Movement Disorders, Vol. 34, Núm. 12, pp. 1851-1863
2018
-
α-synuclein (SNCA) but not dynamin 3 (DNM3) influences age at onset of leucine-rich repeat kinase 2 (LRRK2) Parkinson's disease in Spain
Movement Disorders, Vol. 33, Núm. 4, pp. 637-641
2016
-
COPPADIS-2015 (COhort of Patients with PArkinson's DIsease in Spain, 2015), a global -clinical evaluations, serum biomarkers, genetic studies and neuroimaging- prospective, multicenter, non-interventional, long-term study on Parkinson's disease progression
BMC Neurology, Vol. 16, Núm. 1
-
Comparative blood transcriptome analysis in idiopathic and LRRK2 G2019S-associated Parkinson's disease
Neurobiology of Aging, Vol. 38, pp. 214.e1-214.e5
2015
-
Identification of candidate genes for Parkinson's disease through blood transcriptome analysis in LRRK2-G2019S carriers, idiopathic cases, and controls
Neurobiology of Aging, Vol. 36, Núm. 2, pp. 1105-1109
2014
-
Nonmotor symptoms in LRRK2 G2019S associated Parkinson's disease
PLoS ONE, Vol. 9, Núm. 10
-
Serum uric acid and risk of dementia in Parkinson's disease
Parkinsonism and Related Disorders, Vol. 20, Núm. 6, pp. 637-639
2013
-
Genetic variability related to serum uric acid concentration and risk of Parkinson's disease
Movement Disorders, Vol. 28, Núm. 12, pp. 1737-1740
2012
-
Common variation in the LRRK2 gene is a risk factor for Parkinson's disease
Movement Disorders, Vol. 27, Núm. 14, pp. 1823-1826
2011
-
Aspectos controvertidos en el manejo de gliomas hemisféricos OMS grado II: Revisión de la bibliografía reciente
Revista de Neurologia, Vol. 53, Núm. 12, pp. 747-757
-
High frequency and reduced penetrance of lRRK2 g2019S mutation among Parkinson's disease patients in Cantabria (Spain)
Movement Disorders, Vol. 26, Núm. 13, pp. 2343-2346
-
Replication of MAPT and SNCA, but not PARK16-18, as susceptibility genes for Parkinson's disease
Movement Disorders, Vol. 26, Núm. 5, pp. 819-823